Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536.
Advertisement
Articles by Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536.
Advertisement
Latest Updated Articles
- Study Summary: Use of Enzalutamide for High-Risk, Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER)
Published: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq
2
Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs
3
Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries
4
ACOs Improve Primary, Preventive Care Delivery for Medicare Beneficiaries
5
